Randomized phase III study of docetaxel with or without risedronate in patients with bone metastases from castration-resistant prostate cancer (CRPC): The Netherlands Prostate Study (NePro).
H. J. Meulenbeld
No relevant relationships to disclose
E. D. van Werkhoven
No relevant relationships to disclose
J. L. L. M. Coenen
No relevant relationships to disclose
G. Creemers
No relevant relationships to disclose
O. J. L. Loosveld
No relevant relationships to disclose
P. C. De Jong
No relevant relationships to disclose
A. J. Ten Tije
No relevant relationships to disclose
S. D. Fossa
No relevant relationships to disclose
M. Polee
No relevant relationships to disclose
W. R. Gerritsen
No relevant relationships to disclose
O. Dalesio
No relevant relationships to disclose
R. De Wit
Honoraria - Sanofi (I)
Research Funding - Sanofi